Ejiri Kentaro, Ogawa Aiko, Shimokawahara Hiroto, Matsubara Hiromi
Department of Cardiology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
JACC Asia. 2022 Nov 29;2(7):831-842. doi: 10.1016/j.jacasi.2022.08.011. eCollection 2022 Dec.
Treatment strategy for vascular injury during balloon pulmonary angioplasty (BPA) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) was uncertain.
This study aimed to identify an optimal therapeutic strategy for vascular injury during BPA in patients with CTEPH.
This study reviewed 207 patients with CTEPH and 956 BPA procedures between November 1, 2012 and November 30, 2015. Patients who were diagnosed with vascular injury during BPA, which was defined as angiographic signs or sudden respiratory and hemodynamic defects were included in this study. The study investigated the safety and efficacy of the hierarchically systematic treatment strategy including gelatin sponge embolization (GSE).
More than one-half of the 79 patients and 133 procedures with vascular injury were improved by general treatment with reversal of heparin and high-flow oxygen administration. The investigators performed conventional treatment of proximal vessel occlusion using a guiding or balloon catheter in 47 procedures (35%) in which the culprit vessels could be detected under patients' stable conditions. In 32 procedures (24%) without detected culprit lesions or improvement by conventional treatment, GSE could significantly improve patient condition. The treatment strategy obtained successful bailout in 98% of procedures with vascular injury. No patients who underwent GSE died within 30 days after the treatment. There was no significant difference in cumulative mortality rate (median follow-up: 6.6 years) between groups with or without GSE (15.6% vs 8.2%; adjusted HR: 1.47; 95% CI: 0.25-8.69; 0.67).
Treatment strategy including GSE would be promising for vascular injury during BPA in patients with CTEPH.
慢性血栓栓塞性肺动脉高压(CTEPH)患者在球囊肺动脉血管成形术(BPA)期间血管损伤的治疗策略尚不确定。
本研究旨在确定CTEPH患者在BPA期间血管损伤的最佳治疗策略。
本研究回顾了2012年11月1日至2015年11月30日期间的207例CTEPH患者及956例BPA手术。在BPA期间被诊断为血管损伤(定义为血管造影征象或突发呼吸及血流动力学缺陷)的患者纳入本研究。该研究调查了包括明胶海绵栓塞术(GSE)在内的分层系统治疗策略的安全性和有效性。
79例发生血管损伤的患者及133例手术中,超过一半通过停用肝素及给予高流量吸氧的一般治疗得到改善。在47例手术(35%)中,研究人员在患者病情稳定的情况下使用导引导管或球囊导管对近端血管闭塞进行了常规治疗,这些手术中可检测到罪犯血管。在32例手术(24%)中,未检测到罪犯病变或常规治疗后无改善,GSE可显著改善患者病情。该治疗策略在98%的血管损伤手术中成功实现挽救。接受GSE治疗的患者在治疗后30天内均未死亡。有或无GSE组之间的累积死亡率(中位随访时间:6.6年)无显著差异(15.6%对8.2%;调整后HR:1.47;95%CI:0.25 - 8.69;P = 0.67)。
包括GSE在内的治疗策略对于CTEPH患者在BPA期间的血管损伤可能具有前景。